BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27476581)

  • 1. The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial.
    Chapman MJ; Deane AM; O'Connor SL; Nguyen NQ; Fraser RJ; Richards DB; Hacquoil KE; Vasist Johnson LS; Barton ME; Dukes GE
    Crit Care; 2016 Aug; 20(1):232. PubMed ID: 27476581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study.
    Deane AM; Lamontagne F; Dukes GE; Neil D; Vasist L; Barton ME; Hacquoil K; Ou X; Richards D; Stelfox HT; Mehta S; Day AG; Chapman MJ; Heyland DK
    JPEN J Parenter Enteral Nutr; 2018 Jul; 42(5):949-959. PubMed ID: 29957868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying.
    Hellström PM; Tack J; Johnson LV; Hacquoil K; Barton ME; Richards DB; Alpers DH; Sanger GJ; Dukes GE
    Br J Pharmacol; 2016 Jun; 173(11):1768-77. PubMed ID: 26924243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of camicinal, a novel motilin agonist, on gastro-esophageal function in healthy humans-a randomized placebo controlled trial.
    Hobson R; Farmer AD; Dewit OE; O'Donnell M; Hacquoil K; Robertson D; Barton ME; Dukes GE
    Neurogastroenterol Motil; 2015 Nov; 27(11):1629-37. PubMed ID: 26348542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humans.
    Deloose E; Depoortere I; de Hoon J; Van Hecken A; Dewit OE; Vasist Johnson LS; Barton ME; Dukes GE; Tack J
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28782145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.
    MacLaren R; Kuhl DA; Gervasio JM; Brown RO; Dickerson RN; Livingston TN; Swift K; Headley S; Kudsk KA; Lima JJ
    Crit Care Med; 2000 Feb; 28(2):438-44. PubMed ID: 10708180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
    Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
    Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults.
    MacLaren R; Patrick WD; Hall RI; Rocker GM; Whelan GJ; Lima JJ
    Clin Ther; 2001 Nov; 23(11):1855-66. PubMed ID: 11768837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomized study of the effect of cisapride on gastric emptying in critically ill patients.
    Goldhill DR; Toner CC; Tarling MM; Baxter K; Withington PS; Whelpton R
    Crit Care Med; 1997 Mar; 25(3):447-51. PubMed ID: 9118661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
    Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
    Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill.
    Ritz MA; Chapman MJ; Fraser RJ; Finnis ME; Butler RN; Cmielewski P; Davidson GP; Rea D
    Intensive Care Med; 2005 Jul; 31(7):949-54. PubMed ID: 15940460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
    Marrinan SL; Otiker T; Vasist LS; Gibson RA; Sarai BK; Barton ME; Richards DB; Hellström PM; Nyholm D; Dukes GE; Burn DJ
    Mov Disord; 2018 Feb; 33(2):329-332. PubMed ID: 29278279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations.
    Nguyen NQ; Fraser RJ; Chapman MJ; Bryant LK; Holloway RH; Vozzo R; Wishart J; Feinle-Bisset C; Horowitz M
    Crit Care Med; 2007 Jan; 35(1):82-8. PubMed ID: 17095943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study.
    Dive A; Miesse C; Galanti L; Jamart J; Evrard P; Gonzalez M; Installé E
    Crit Care Med; 1995 Aug; 23(8):1356-62. PubMed ID: 7634805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric emptying in critically ill patients is accelerated by adding cisapride to a standard enteral feeding protocol: results of a prospective, randomized, controlled trial.
    Spapen HD; Duinslaeger L; Diltoer M; Gillet R; Bossuyt A; Huyghens LP
    Crit Care Med; 1995 Mar; 23(3):481-5. PubMed ID: 7874898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition.
    Landzinski J; Kiser TH; Fish DN; Wischmeyer PE; MacLaren R
    JPEN J Parenter Enteral Nutr; 2008; 32(1):45-50. PubMed ID: 18165446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding.
    Chapman MJ; Fraser RJ; Kluger MT; Buist MD; De Nichilo DJ
    Crit Care Med; 2000 Jul; 28(7):2334-7. PubMed ID: 10921561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal hormone concentrations associated with gastric feeding in critically ill patients.
    Crona D; MacLaren R
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2):189-96. PubMed ID: 21799189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metoclopramide improves gastric but not gallbladder emptying in cardiac surgery patients with early intragastric enteral feeding: randomized controlled trial.
    Sustić A; Zelić M; Protić A; Zupan Z; Simić O; Desa K
    Croat Med J; 2005 Apr; 46(2):239-44. PubMed ID: 15849845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisapride improves gastric emptying in mechanically ventilated, critically ill patients. A randomized, double-blind trial.
    Heyland DK; Tougas G; Cook DJ; Guyatt GH
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1678-83. PubMed ID: 8970354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.